Altheia Science

Private

MilanHealthcare & Life Scienceshttps://altheiascience.com/

Last Round

Series A

Dec 19, 2018

Total Funding Raised

$19.3M

Company Overview

Altheia Science is a biotechnology company that develops cell and gene therapy strategies to treat autoimmune diseases and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyhematopoietic stem cellsautoimmune disease treatmentex vivo gene modificationlentiviral engineeringbiotechnologycell therapygene expression modulationcontract development and manufacturing organizationCDMOprecision medicinedrug discoveryclinical trialsbiotech startupcurative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Altheia Science Comps

Public and private peers based on sector, stage, and business model.

Altheia Science comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Altheia Science Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 19, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Paolo Rizzardi

Co-Founder, Chairman & CEO

Founding Team

Altheia Science Investors

Notable investors and investment history

Altheia Science investors
Investor	Rounds
Fin Posillipo S.p.A.	Series A
AurorA-TT	Series A
Advanced Accelerator Applications	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 1, 2026
Monthly visitors increased 636% MoM.

View all signals

Altheia Science Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Altheia Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Altheia Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan

Employee Range4

Year Founded2017

Last FundingDec 19, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.